World
Coronavirus Vaccine From Moderna Shows Early Signs of Viral Immune Response
- Shares rise to record; first vaccine result in humans
- Company plans to take shot into phase 3 testing in July
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
An experimental vaccine from the U.S. biotechnology company Moderna Inc. showed signs that it can create an immune-system response to fend off the new coronavirus, offering tentative hopes in the global effort to combat the pandemic.